As US-China pharma rivalry heats up, can Hong Kong’s US$8b fund be the global bridge?
--------------------------------------------------------------------
Source: South China Morning Post
Published: 2026-08-07 20:12 UTC+10:00
Section: United States
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Asia, China, World News, Business & Economy, Asia Pacific
--------------------------------------------------------------------
Snippet:
Hong Kong Investment Corporation is stepping up its efforts to position itself amid Beijing’s challenge to US pharmaceutical dominance
--------------------------------------------------------------------